RenovoRx, Inc.
For the period ended Mar 31, 2026. Filed May 14, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 14, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Form | File No. | Exhibit | Filing Date |
| 3.1 | Sixth Amended and Restated Certificate of Incorporation of RenovoRx, Inc. | 8-K | 001-40738 | 3.1 | August 31, 2021 |
| 3.2 | Amended and Restated Bylaws of RenovoRx, Inc. | 8-K | 001-40738 | 3.1 | September 11, 2023 |
| 4.1 | Form of Private Common Stock Warrant (related to the 2020 Convertible Notes and 2021 Convertible Notes) | 10-Q | 001-40738 | 4.1 | November 15, 2021 |
| 4.2 | Form of Underwriter’s Warrant | S-1 | 333-258071 | 4.1 | August 25, 2021 |
| 4.3 | Form of Warrant Agent Agreement (including the terms of the Warrants) | S-1 | 333-258071 | 4.2 | August 25, 2021 |
| 4.4 | Specimen Stock Certificate evidencing the Shares of Common Stock | S-1 | 333-258071 | 4.4 | August 25, 2021 |
| 4.5 | Form of Warrant Certificate | S-1 | 333-258071 | 4.5 | August 25, 2021 |
| 4.6 | Form of Pre-Funded Common Stock Purchase Warrant | 8-K | 001-40738 | 4.1 | April 3, 2023 |
| 4.7 | Form of Common Stock Purchase Warrant | 8-K | 001-40738 | 4.2 | April 3, 2023 |
| 4.8 | Warrant to Purchase Common Stock of RenovoRx, Inc. | 8-K | 001-40738 | 10.3 | January 29, 2024 |
| 4.9 | RenovoRx Placement Agent Warrant | 8-K | 001-40738 | 10.5 | January 29, 2024 |
| 4.10 | Form of Pre-Funded Common Stock Purchase Warrant of RenovoRx, Inc. | 8-K | 001-40738 | 10.2 | April 15, 2024 |
| 4.11 | Form of Series A Warrant to Purchase Common Stock of RenovoRx, Inc. | 8-K | 001-40738 | 10.3 | April 15, 2024 |
| 4.12 | Form of Series B Warrant to Purchase Common Stock of RenovoRx, Inc. | 8-K | 001-40738 | 10.4 | April 15, 2024 |
| 4.13 | Form of Placement Agent Warrant to Purchase Common Stock of RenovoRx, Inc. | 8-K | 001-40738 | 10.5 | April 15, 2024 |
| 4.14 | Common Stock Purchase Warrant Issued to Medical Murray, Inc., dated September 25, 2024 | 10-Q | 001-40738 | 4.14 | November 13, 2024 |
| 4.15 | Form of Underwriter Warrant issued in February 2025 Public Offering | 8-K | 001-40738 | 4.1 | February 10, 2025 |
| 4.16 | Form of Pre-Funded Warrant Issued to Investors in the March 2026 Private Placement | 8-K | 001-40738 | 4.1 | March 23, 2026 |
| 4.17 | Form of Milestone Warrant Issued to Investors in the March 2026 Private Placement | 8-K | 001-40738 | 4.2 | March 23, 2026 |
| 10.1+# | Consulting Agreement, dated February 4, 2026, by and between the Company and Mark Voll | 8-K | 001-40738 | 10.1 | February 6, 2026 |
| 10.2 | Form of Securities Purchase Agreement in the March 2026 Private Placement | 8-K | 001-40738 | 10.1 | March 23, 2026 |
| 10.3+ | Agah Offer Letter, dated March 24, 2026 and effective February 27, 2026, by and between the Company and Ramtin Agah | 8-K | 001-40738 | 10.1 | March 27, 2026 |
| 31.1 | Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | Filed herewith | |||
| 31.2 | Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted | Filed herewith | |||
| Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
| 32.1† | Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | Furnished herewith |
| 32.2† | Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | Furnished herewith |
| 101.INS | Inline XBRL Instance Document-the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document | Filed herewith |
| 101.SCH | Inline XBRL Taxonomy Extension Schema with Embedded Linkbase Documents | Filed herewith |
| 104 | Cover Page formatted as Inline XBRL and contained in Exhibit 101 | Filed herewith |
† The certifications attached as Exhibits 32.1 and 32.2 that accompany this Quarterly Report on Form 10-Q are deemed furnished and not filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.
- Certain information has been omitted from this exhibit pursuant to Item 601(a)(6) or Item 601(b)(10)(iv) of Regulation S-K.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.